Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Glutathione status in Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Hemi-stereotypies symptomatic to aneurysm: Differential diagnosis of tardive dyskinesia
Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Hemifacial spasm – Therapeutic assessment of botulinum toxin
Myoclonus · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Hereditary atypical parkinsonism with novel mutation of the VPS35 and FBXO7 genes
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson’s disease (PD)
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
High throughput pooled-DNA sequencing of mendelian/susceptibility Parkinson’s disease genes in Spanish population
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Histochemical evaluation of the effect of vitamin E on cyanide–induced damage on the prefrontal cortex of Sprague Dawley rats
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Histone deacetylase 4 is regulated by microRNA 128 in SH-SY5Y cells of Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
How do we clinically distinguish subtypes of myoclonus? A retrospective study
Myoclonus · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 48
- Next Page»